of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit
Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27
Constructions (2) Registration of 100 drugs formulas (54 formulas for human medicine and 46 formulas for animals) owned by the seller (3) Registration of special drug formulas, consisting of 12 formulas including
the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or
involves severely illegal business. For example, human trafficking, drug smuggling or money laundering etc. Moreover, the issuer must not act in violation or non-compliance with the law, which may cause
increase of 463.3 MB and 700.2 MB or increase of 36.6% and 68.0%, respectively. This is because the Company had delivered many large-scale projects which had just been auctioned in early 2019. Those large
745.8 MB or increase of 4.0% and 70.8%, respectively. This is because the Company had delivered many large-scale projects which had been ongoing from Q1–2019 and Q2–2019, such as the High-Speed Internet
157.0 MB and 221.6 MB, respectively. This is because the Company had delivered many large-scale projects which had just been auctioned in Q1–2019. In fact, those large-scale projects had delayed their
establishment of the Company. In fact, the majority of the company’s revenue was revenue from sale and service. In 2019, the Company had received many large-scale projects from government agencies and state
businesses and FinTech startups to make the most of financial innovations, but also promote a full-scale digital economy.?The FinTech Draft Act contains four core matters: (1) strengthening the confidence in